Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07128290 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma

Study acronym: PEHRICCA
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this trial is to determine whether the combination of CISGEM and Rilvegostomig during the perioperative period works to improve outcomes of patient undergoing surgery of high-risk of intrahepatic cholangiocarcinoma
Trial Details
NCT Number NCT07128290
Lead Sponsor Federation Francophone de Cancerologie Digestive
Conditions
(from sponsor)		 Intrahepatic Cholangiocarcinoma (Icc)
Related terms Cholangiocarcinoma, Cirrhosis, Familial, with Pulmonary Hypertension
Enrollment 49 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov